2022 ICD-10-PCS Procedure Code XW023X7

Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7

2022 - New Code

Billable/Specific Code

ICD-10-PCS XW023X7 is a specific/billable code that can be used to indicate a procedure.
ICD-10-PCS XW023X7 is a new 2022 ICD-10-PCS code that became effective on October 1, 2021.

Code History